As a primary care physician who has spent decades helping patients navigate the byzantine complexities of our healthcare system, I researched the new White House unveiling of the self-referential TrumpRx (ew) with a mix of hope and concern. President Trump proclaimed it “one of the most transformative healthcare initiatives of all time,” promising Americans dramatic discounts on prescription medications. But after examining the platform this morning and reviewing independent analyses, I’m deeply skeptical that this initiative will meaningfully help my patients—and worried it may actually harm them…
But here’s the first thing that concerns me: these astronomical discount percentages are calculated against list prices, the sticker prices that virtually no one actually pays. It’s like a car dealership advertising 30% off MSRP when the real negotiated price was always going to be much lower. This mathematical sleight-of-hand creates the illusion of historic savings while obscuring what patients truly pay through insurance copays or existing discount programs, which is often much lower already.
Perhaps most troubling is what multiple independent analyses have revealed: approximately half of the 43 drugs featured on TrumpRx already have significantly cheaper generic alternatives available elsewhere. - Daily Kos
Thursday, February 12, 2026
Trump Rx is just another Trump con
Upon examination, it’s little different from anything else with Trump’s name on it. More here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment